Hideya Takeuchi
Overview
Explore the profile of Hideya Takeuchi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
260
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mita J, Tada K, Kuboyama Y, Hiroshige S, Nakamura S, Takahashi J, et al.
Surg Case Rep
. 2022 Oct;
8(1):195.
PMID: 36214924
Background: Gastrointestinal stromal tumors (GISTs) are rare mesenchymal tumors, but are the most common mesenchymal tumors of the gastrointestinal tract. The risk classification of GISTs is based on the tumor...
2.
Okamoto T, Miyawaki M, Toyokawa G, Karashima T, Abe M, Takumi Y, et al.
Interact Cardiovasc Thorac Surg
. 2021 Sep;
34(2):219-226.
PMID: 34561707
Objectives: The ground-glass component of part-solid tumour (PST) was eliminated as a clinical T (cT) descriptor in the eighth edition of the tumour, node and metastasis (TNM) staging system. We...
3.
Miyawaki M, Jikumaru M, Kamada K, Daiki N, Abe M, Anami K, et al.
Surg Case Rep
. 2021 Jul;
7(1):159.
PMID: 34240257
Background: Myotonic dystrophy (dystrophia myotonica [DM]) is an autosomal-dominant inheritance, and myasthenia gravis (MG) is an autoimmune disease characterized by weakness of skeletal muscles. Cases of both DM and MG...
4.
Noda D, Abe M, Takumi Y, Anami K, Miyawaki M, Takeuchi H, et al.
Surg Case Rep
. 2021 Jan;
7(1):28.
PMID: 33471222
Background: Surgery is an effective treatment for desmoid fibromatosis, but it may be difficult, depending on the location or local spread of the tumor, and the decision to perform surgery...
5.
Takeuchi H, Noda D, Abe M, Anami K, Miyawaki M, Osoegawa A, et al.
Anticancer Res
. 2020 Jul;
40(7):3947-3952.
PMID: 32620636
Aim: This study aimed to evaluate plateletcrit (PCT) and platelet distribution width-to-PCT ratio (PDW/PCT) as potential prognostic biomarkers in patients with breast cancer. Patients And Methods: Information of 337 patients...
6.
Kubo N, Kawanaka H, Hiroshige S, Tajiri H, Egashira A, Takeuchi H, et al.
Ann Gastroenterol Surg
. 2019 Dec;
3(6):630-637.
PMID: 31788651
Aim: Sarcopenia has been reported as a prognostic predictor in various conditions; however, it has not been examined in patients with perforation panperitonitis. Methods: A total of 103 consecutive patients...
7.
Abe M, Osoegawa A, Karashima T, Takumi Y, Kobayashi R, Hashimoto T, et al.
Int Cancer Conf J
. 2019 Jun;
8(2):81-85.
PMID: 31149553
Acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors remains the main hurdle in treating EGFR-mutated lung cancer. Besides, when leptomeningeal carcinomatosis occurs during treatment, it often leads to...
8.
Takeuchi H, Abe M, Takumi Y, Hashimoto T, Miyawaki M, Okamoto T, et al.
Sci Rep
. 2019 Mar;
9(1):3033.
PMID: 30816333
Red cell distribution width (RDW) to platelet ratio (RPR) is a prognosticator in acute pancreatitis and myocardial infarction; however, the prognostic values of RDW and RPR in breast cancer have...
9.
Hashimoto T, Osoegawa A, Takumi Y, Abe M, Kobayashi R, Miyawaki M, et al.
Lung Cancer
. 2018 Oct;
124:241-247.
PMID: 30268468
Background: Although intratumoral heterogeneity is commonly observed in several cancers, few studies have shown its presence in EGFR-mutated lung cancer. We performed immunohistochemistry to analyze the intratumoral heterogeneity in EGFR-mutated...
10.
Osoegawa A, Hashimoto T, Takumi Y, Abe M, Yamada T, Kobayashi R, et al.
Invest New Drugs
. 2018 Mar;
36(6):999-1005.
PMID: 29594878
Background Acquired resistance (AR) to an epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) is a common event, and several underlying mechanisms, including T790 M, MET amplification and PTEN downregulation, have...